Osteoporosis in Men: An Update on the Epidemiology, Clinical Evaluation, Current Treatments and Treatments in Development

PRESENTER: Jeffrey Curtis, MD, MS, MPH

University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology
William J. Koopman Endowed Professor in Rheumatology and Immunology
Director, UAB Arthritis Clinical Intervention Program
Co-Director, UAB Center for Education and Research on Therapeutics (CERTS)
Co-Director, UAB PharmacoEpidemiology and Economic Research (PEER) Group
Birmingham, AL

Credits: 0.5

Release Date: July 28, 2016

Target Audience:This activity has been designed to meet the educational needs of rheumatologists, physician assistants, and nurse practitioners involved in the care of patients with osteoporosis.

Learning Objectives: After the completion of this activity, participants should be able to:

  • Discuss the epidemiology of osteoporosis in men
  • Describe the pathophysiology of osteoporosis in men
  • Review approved treatments for the treatment of osteoporosis in men
  • PHYSICIAN ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of Purdue University College of Pharmacy and Focus Medical Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation: Purdue University College of Pharmacy designates this enduring activity for a maximum of
    0.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Disclosure Statement: All faculty and staff involved in the planning, review or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

    All additional planning committee members, reviewers and Focus Medical Communications and Purdue University College of Pharmacy staff have no relationships to disclose.

    Dr. Curtis has received grants and/or research support from AbbVie Inc., Amgen, Bristol-Myers Squibb, Crescendo, CORRONA, Genentech, Janssen, Pfizer and UCB. He has also received honorarium from AbbVie Inc., Amgen, Bristol-Myers Squibb, Crescendo, CORRONA, Genentech, Janssen, Pfizer and UCB.

    This activity is supported by AbbVie, Inc., Crescendo Bioscience, Inc., Janssen Biotech, Inc., Eli Lilly and Company and Pfizer Inc.